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ABSTRACT
Type 2 diabetes mellitus is a significant health issue, as it requires patients to perform daily selfmanagement activities. One in every three Americans with Type 2 diabetes has limited or low
health literacy skills. Limited or low health literacy skills can impact a patient’s overall health
outcome; therefore, a critical element for disease management and patient adherence is health
literacy. The purpose of this three-month scholarly project was to determine if the utilization of
an educational intervention specific to one’s level of health literacy, combined with a short
message service reinforcement tool, could improve glycemic control and self-efficacy in Type 2
diabetes mellitus patients with limited and low HL. A sample of four participants was recruited
for this scholarly project. Participants completed pre and post self-efficacy and health literacy
questionnaires. During the three-month intervention phase, participants interacted with the
project leader utilizing the text messaging reinforcement tool. After the three-month intervention
phase, participants had an overall 9% increase in self-efficacy confidence, a 42% overall increase
in health literacy knowledge, and an overall HbA1c mean value reduction of 0.5%. This
combination therapy intervention is easy and convenient for health care providers and Type 2
diabetes mellitus patients with limited or low health literacy. This intervention is an efficient and
effective method to improve patients self-efficacy and diabetes knowledge; furthermore, this
method improves patient self-management skills, glycemic control, and patient longevity.
Keywords: diabetes mellitus, self-efficacy, self-management, short message service,
health literacy
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SECTION ONE: INTRODUCTION
Diabetes mellitus (DM) is a significant, global health problem; 425 million people
worldwide have diabetes, and cases are expected to rise by 204 million by 2045 (Abdullah, Liew,
Salim, & Chinna, 2019). To achieve disease control, individuals with DM perform
approximately 95% of their independent daily self-management activities (Abdullah et al., 2019).
For patients to make appropriate health decisions and manage one’s disease, fundamental health
literacy (HL) is critical (Abdullah et al., 2019). Limited or low HL has been associated with
poorer outcomes, less health-related knowledge, less adherence, and poor self-care behaviors
(Abdullah et al., 2019; Koonce, Giuse, Kusnoor, Hurley, & Ye, 2015). Therefore, the purpose of
this scholarly project was to identify if an HL-specific educational program, when combined
with a short message service (SMS) intervention, could improve glycemic control and selfefficacy in a patient with Type 2 diabetes mellitus (T2DM) over a three-month period.
Background
In 2017, 30.3 million people (9.4% of the total population) in the United States had a
diagnosis of DM (National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK],
2019). An estimated 23.1 million people (7.2% of the total population) have been diagnosed,
while roughly 7.2 million adults have not (NIDDK, 2019). There are three classifications of
diabetes: Type 1 (T1DM), T2DM, and gestational. For the purpose of this scholarly project, the
primary focus was T2DM.
Based on the 83,564 death certificates in 2017, DM was the seventh-leading cause of
death in the US (American Diabetes Association [ADA], n.d.). The total annual cost of diabetesrelated treatment in 2017 was $327 billion; of that value, $237 billion was for direct medical
costs (ADA, n.d.). The ADA (n.d.) indicates the average medical expenditures in 2017 for those
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diagnosed with diabetes were 2.3 times higher than for those without a diabetes diagnosis. The
National Diabetes Statistic Report from 2015 identified the following: (a) an annual diagnosis
rate of 1.5 million new cases, (b) diabetes prevalence increases at age 65 and older (25%), (c)
prevalence is higher among American Indians/Alaska Natives (15.1%), (d) prevalence varies
with level of education, increasing with HL, and (e) the highest prevalence rates are in the
southern and Appalachian areas of the US (National Center for Chronic Disease Prevention and
Health Promotion [NCCDPHP], 2017).
Representing 90%–95% of all diabetes diagnoses, T2DM is a result of insulin resistance
(NCCDPHP, 2017). Insulin resistance occurs as a result of weight gain, obesity, and physical
inactivity (NIDDK, 2019). DM can lead to microvascular and macrovascular complications.
Microvascular complications include neuropathy and retinopathy. Macrovascular complications
include peripheral vascular disease, coronary artery disease, and cerebrovascular accident.
Bohyuun, Song, and Kim (2019) indicated the ultimate treatment goal for patients with
T2DM is to maintain a healthy lifestyle while preventing chronic complications; this can be
achieved through effective glycemic control, self-efficacy, and self-care management behaviors.
Until recently, diabetes self-care management research has focused primarily on how to improve
self-management behaviors; however, studies now suggest that in order to improve these
behaviors and self-efficacy, educational programs need to be tailored to patient learning style and
preferences (Bohyuun et al., 2019; Koonce et al., 2015). Self-efficacy is the belief that a specific
outcome will occur as a result of a specific behavioral change; it is affected by self-management
and problem-solving (Bohyuun et al., 2019; Gedik, 2017). Patient self-efficacy is positively
associated with improved T2DM control through self-management behaviors (Amer, Mohamed,
Elbur, Abdelaziz, & Elrayah, 2018; Tharek et al., 2018).

COMBINATION THERAPY FOR TYPE TWO DIABETES MELLITUS

13

In 2010, the Centers for Disease Control and Prevention established the National
Diabetes Prevention Program to encourage lifestyle modifications through diet and exercise to
prevent or delay T2DM and/or complications (NCCDPHP, 2017). Additional partnerships to
spread diabetes awareness include the National Institutes of Health, the ADA, the Ad Council,
and the American Medical Association. All partnerships have been made in hopes of improving
diabetes self-management education access (NCCDPHP, 2017).
The U.S. Department of Education (2019) revealed 43 million adults have low literacy
skills, or approximately one in five Americans. Low literacy skills are strongly correlated with
low socioeconomic status (SES); however, as of 2019, 96% of all Americans have a mobile
device, and 26% of those classified as low SES have smart phones (Pew Research Center, 2019).
Literature continuously identifies the significance of lifestyle modification through diet and
exercise; yet, only 30% of T2DM patients achieve blood pressure, glycemic control, and
cholesterol targets (Abdullah et al., 2019). In recognizing that current guidelines continue to
stress the importance of simple lifestyle modifications, one must ask the question, why are these
measures not being met? To achieve a therapeutic outcome in diabetes management, the key is
to identify an individual’s HL level, target patient-specific education, and utilize current
resources (mobile devices) to improve self-efficacy, self-management behaviors, and glycemic
control (Abaza & Marschollek, 2017; Amer et al., 2018; Koonce et al., 2015). Therefore, this
scholarly project targeted T2DM patients with limited or low HL with an end goal of improving
self-efficacy confidence and glycemic control using a basic HL educational pamphlet with a
mobile reinforcement intervention tool.
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Problem Statement
Despite treatment, prevention pursuits, and clinical awareness, T2DM is a continuously
evolving disease. If the current trend continues, by year 2050, one in three American adults will
have DM (Koonce et al., 2015). Diabetes is a threat to mankind; prevalence is found to be
higher among minority and aging populations, individuals with low HL, and those classified as
low SES. A clear association has been identified between diabetes knowledge and HL;
therefore, to improve self-efficacy, self-management behaviors, and glycemic control, a tailored
educational program is imperative to halt disease progression.
Purpose of the Project
The purpose of this scholarly project was to determine if the utilization of an HL-specific
educational intervention combined with an SMS reinforcement tool could improve glycemic
control and self-efficacy in T2DM patients. T2DM patients who are classified as having low HL
and low SES often receive minimal disease education and self-management skill training.
Therefore, the aim of this project intervention was to improve participant blood glucose levels,
confidence in disease management, and overall quality of life.
Clinical Question
In patients with Type 2 diabetes and low health literacy, does HL-specific diabetes
education combined with an SMS intervention, when compared to previous standard diabetes
education, improve glycemic control and self-efficacy over a three-month period?
SECTION TWO: LITERATURE REVIEW
The purpose of this literature review is to explore DM and provide insight on the
association between the chosen disease process and self-efficacy, self-management behaviors,
and HL. Qualitative and quantitative research provide sufficient evidence to support a tailored,
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HL-specific diabetes educational intervention and the importance of self-efficacy confidence in
relation to positive self-care behaviors and glycemic control. This literature review identifies the
benefits of automated text messages and tailored educational programs. To guide the writer
through the evidence-based practice (EBP) process, the Iowa Model was utilized for the
conceptual framework; to provide support and guidance for each project participant, the
transtheoretical model was used. Chapter Two is divided into the following sections: search
strategy, critical appraisal, synthesis, conceptual framework, theoretical framework, and
summary.
Search Strategy
In an effort to provide the most applicable evidence, a comprehensive review of the
literature using electronic databases was performed. The databases included CINAHL, Cochrane
Library, Pubmed, Medline, and Google Scholar. For the purpose of this research topic, the
following keywords were utilized: diabetes mellitus, self-efficacy, self-management, health
literacy, and short message service. A total of 3,652 articles resulted; the addition of health
literacy narrowed the search to 271 peer-reviewed articles. The original search that resulted in
3,652 articles was conducted a second time with the addition of keyword SMS; 232 articles
resulted. Articles were then excluded using the following parameters: T1DM, gestational
diabetes, pregnancy, and intellectual and developmental disabilities. Results were limited to
articles published in the English language within the previous five years (2015–2019).
Critical Appraisal
Fifteen articles were chosen for this scholarly project; additional resources included the
ADA and the NIDDK. Each article selected was analyzed using a summary and synthesis tool,
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then evaluated according to Melnyk’s levels of evidence (Melnyk & Fineout-Overholt, 2014).
The table of evidence is provided in Appendix A.
Systematic reviews. A systematic review of 29 research studies involving 13,457 T2DM
patients from seven different countries was conducted by Abdullah et al. (2019). This systematic
review, a level one research study, was conducted to summarize and report the current global
evidence on the prevalence of limited HL in patients with T2DM (Abdullah et al., 2019). The
authors of the study completed an appropriate systematic review by searching five electronic
databases: MEDLINE, PsychINFO, EMBASE, CINAHL, and ERIC (Abdullah et al., 2019).
Authors concluded that HL tools and HL prevalence varied widely among different countries,
and that one in every three patients in the United States with T2DM had limited HL.
Randomized controlled trials. Six randomized controlled trials (RCTs) were utilized for
this literature review. Abaza and Marschollek (2017) completed a 12-week RCT to examine the
impact of SMS education on self-management behaviors and glycemic control when compared
to standard paper-based education methods among patients with T2DM in Egypt. Seventy-three
English-speaking, Type 2 diabetes patients aged 18 years and older were included in this study,
34 in the intervention group and 39 in the control group. A 1% reduction in HbA1c values (p =
0.003) was noted in the intervention group; secondary outcomes included improvements in
medication adherence, knowledge scores, and self-efficacy values (Abaza & Marschollek, 2017).
Two short-term RCTs provided significant evidence to support the utilization of
automated text messages in the improvement of patient adherence and the importance of
targeting HL when educating patients with T2DM. The mobile health system, an SMS
intervention, created to target patient adherence was well accepted and utilized among T2DM
patients after four short weeks (Fioravanti, Fico, Salvi, García-Betances, & Arredondo, 2015).
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The intervention resulted in an increase in medication adherence in both T1DM and T2DM
patients. However, future outcomes could be affected due to the short time frame, small sample
size (26 intervention patients), and limited clinical location (Fioravanti et al., 2015). Koonce et
al. (2015) completed an RCT with 160 patients with T2DM to investigate the correlation of
targeted HL education materials to learning styles in a community clinic. After two weeks, the
mean value of diabetes knowledge questions answered by the intervention group had
significantly increased (p = 0.0000), and after four weeks, the increase continued (p = 0.00).
This RCT provided key evidence to support an increase in patients’ diabetes knowledge after
exposure to educational materials tailored to their learning style, preference, and HL level
(Koonce et al., 2015).
An RCT to examine the effectiveness of SMS reminder messages on antiretroviral
prophylaxis among human immunodeficiency virus (HIV)-positive youths was conducted on 332
participants from two HIV clinics in Kampala (Linnemayr et al., 2017). This study identified
SMS reminder messages are not always as effective in behavioral change among HIV-positive
youth (Linnemayr et al., 2017). To compare face-to-face interviews and text messages for a
public health study, a secondary RCT was completed in several rural areas of China (van
Velthoven et al., 2018). This study identified 1,014 potential participants. Of the gathered
participants, 651 agreed to participate; however, only 356 completed the SMS survey (van
Velthoven et al., 2018). The public health study revealed SMS data produced similar results
when compared to face-to-face surveys in this middle-income area (van Velthoven et al., 2018).
Both RCTs provided a useful evaluation of the SMS as an intervention tool; however,
weaknesses identified among both studies were poor communication, short/unknown time
frames, centralized locations, and poor response rates.
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Quasi-experimental. Two quasi-experimental research studies utilized SMS
interventions to authenticate short-term improvement with medication adherence, physical
activity, self-efficacy, and perceived family support. Lari, Noroozi, and Tahmasebi (2018)
evaluated 74 patients with T2DM over a 12-week period. When compared to the control group,
the intervention SMS group produced changes in the “mean scores of perceived self-efficacy (p
= 0.001) and family support (p = 0.046)” (Lari et al., 2018, p. 67); in addition, perceived barriers
were significantly reduced over time (p < 0.001).
The MEssaging for Diabetes (MED) SMS intervention created by Nelson et al. (2016)
utilized 80 patients with T2DM classified as low SES. When compared to baseline studies,
patient adherence measures improved after four and eight weeks (Nelson et al., 2016). At the
completion of week 12, the MED SMS intervention produced a positive short-term impact on
medication adherence but not on glycemic control (Nelson et al., 2016). Both quasiexperimental studies were conducted in single primary care clinics over a short-term period;
these limitations could affect future research.
Cross-sectional. To evaluate and examine the relationship between self-efficacy, selfcare behaviors, and glycemic control in a patient with T2DM, five cross-sectional research
studies were evaluated. Self-efficacy among patients with T2DM is significantly associated with
glycemic control and self-care activities (Amer et al., 2018; Tharek et al., 2018). A significant
association between diabetes appraisal and diet knowledge (p = 0.047) was identified by Cheng,
Sit, Leung, and Li (2016). Further research demonstrated a positive correlation between higher
self-efficacy scores and diabetes self-care management behaviors (Bohyun, Youngshin, & Jong,
2019; Tharek et al., 2018). Huygens et al. (2017) investigated the relationship between patients’
willingness to self-monitor and control of their chronic illnesses using 627 participants from a
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Dutch panel. A patient’s willingness to self-monitor their disease depended highly on their
disease type; patients with T2DM are more likely to self-monitor their disease(s) when provided
appropriate self-monitoring applications (Huygens et al., 2017). Four of the five cross-sectional
studies were conducted in one location, convenient nonprobable sampling methods were used,
and self-reported measures were utilized for data collection; therefore, these limitations could
affect research outcomes (Amer et al., 2018; Bohyun et al., 2019; Cheng et al., 2016; Tharek et
al., 2018). The fifth study utilized a broad sample size containing various chronic illnesses; each
chronic disease had a different number of participants, some more involved than others. The
centralized location, broad sample size, and self-reported data measures were limitations within
that study (Huygens et al., 2017).
Descriptive design. Gedik and Kocoglu (2018) collected data from April 2015 to June
2015 on 216 patients with T2DM. This nonexperimental, descriptive survey was conducted to
assess the self-efficacy levels of T2DM patients living in rural Turkish areas. The
nonexperimental survey utilized the Self-Efficacy for Type 2 Diabetes tool and found that
individuals living in the rural areas of Turkey had moderate self-efficacy levels and poor disease
management (Gedik & Kocoglu, 2018). Due to the localized sample and the sample size,
findings from the survey are unable to be generalized; however, the survey could be used as
evidence to support clinical change in that patients living in rural areas with T2DM who need
diabetes education programs to improve self-efficacy levels.
Synthesis
T2DM is a chronic condition that can result in short-term and long-term complications.
The project leader compiled four common themes from the literature review. The four dominant
themes were HL interventions for patients with T2DM, diabetes self-efficacy and self-
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management promotion techniques, mobile technology and automated text message use, and
diabetes educational programs in rural locations. To improve self-efficacy, self-management
behaviors, and glycemic control, each identified theme provided interventions to assist low-HL
patients with T2DM.
Health literacy interventions for patients with T2DM. One in every three patients with
T2DM in the United States are classified as having limited or low HL (Abdullah et al., 2019).
Diabetes patient knowledge can significantly increase when patients are exposed to educational
materials tailored to their learning preference, style, and HL level (Koonce et al., 2015).
Promotion of diabetes self-efficacy and self-management. Self-efficacy and selfmanagement are strongly connected with patient adherence and glycemic control improvements
(Abaza & Marschollek, 2017; Amer et al., 2018; Bohyun et al., 2019). Cheng et al. (2016)
emphasized that patients encounter numerous barriers in the course of diabetes self-management.
A fundamental association was identified between self-efficacy barriers, diabetes knowledge,
and an individual’s willingness to self-monitor their disease (Cheng et al., 2016; Huygens et al.,
2017). Higher self-efficacy scores in patients with T2DM were correlated with better self-care
behaviors and improved glycemic control (Tharek et al., 2018).
Mobile technology and automated text message use. SMS interventions such as
standard text messaging, the MED mobile app, and the mobile health system have proven to
have positive outcomes when utilized with T2DM patients (Fioravanti et al., 2015; Lari et al.,
2018; Nelson et al., 2016). When compared to standard face-to-face DM education, van
Velthoven et al. (2018) revealed similar data were produced by education utilizing SMS
interventions; however, a 1% reduction in HbA1c values was reported by Abaza and
Marschollek (2017) during a 12-week RCT using non-standard methods (SMS education). A
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previous study conducted by Linnemayr et al. (2017) reported SMS reminder interventions were
helpful in the promotion of medication adherence, although it was not as effective in behavioral
change. Additional research studies proved self-management behaviors are correlated with
short-term improvements, including weight loss and reduction in waist circumference and lipid
profiles (Lari et al., 2018; Silina, Tessma, Senkane, Krievina, & Bahs, 2017). When text
messaging interventions were utilized, a positive association was seen with prescription
adherence, diet, and physical activity (Abaza & Marschollek, 2017; Fioravanti et al., 2015;
Nelson et al., 2016).
Diabetes education programs in rural locations. Gedik and Kocoglu (2018) found
patients living in rural areas of Turkey had moderate self-efficacy levels and poor disease
management skills. Diabetes education is a critical component of patient success for chronic
disease management. Therefore, diabetes education programs should be established and tailored
to patient needs and preference within specified (rural) areas. This scholarly project intervention
created an HL-specific, DM educational program within a rural area of North Carolina with an
objective to improve self-efficacy and disease management skills.
Conceptual Framework
The Iowa Model, created in the 1990s and revised in 2015, was utilized as the conceptual
framework for this scholarly project (Iowa Model Collaborative, 2017). Frequently used to
improve quality of care, the Iowa Model guides users through the EBP process using a sevenstep algorithm (White, Dudley-Brown, & Terhaar, 2016). To promote health care excellence,
Step 1 of 7 begins with the identification of a trigger. Once a trigger is identified, the purpose or
clinical question is created, then a team is formed (Step 3), the evidence is evaluated (Step 4), an
EBP intervention is designed (Step 5), the intervention is implemented (Step 6), and, finally, the

COMBINATION THERAPY FOR TYPE TWO DIABETES MELLITUS

22

intervention is evaluated (Iowa Model Collaborative, 2017). If the intervention is successful and
the change is proven to be effective, then the change can be integrated within clinical practice.
Permission to use and/or reproduce the Iowa Model Revised: Evidence-Based Practice to
Promote Excellence in Health Care for this scholarly project was granted by the University of
Iowa Hospitals and Clinics on October 31, 2019 (see Appendix C).
Trigger identification and purpose statement. In the United States, 9.4% of the
population has a diagnosis of DM. One in every five Americans is classified as having low HL;
one in every three Americans diagnosed with T2DM has limited or low HL skills. DM is a
chronic illness, requiring approximately 95% of independent daily self-management skills;
therefore, adequate self-efficacy and self-management activities are essential for disease
management. A patient who is classified with limited or low HL skills will often have poorer
health outcomes, just as those who display poor self-efficacy and self-management abilities will
(Abdullah et al., 2019; Abaza & Marschollek, 2017; Bohyun et al., 2019). The topic of interest
for this project was the association between low HL and self-efficacy in patients with T2DM.
Therefore, the project leader began communicating with local primary care offices to identify
common management barriers between health care providers and patients with T2DM. Common
barriers included low HL, low income, limited transportation, inadequate access to health
insurance, and physician/provider shortage (Rural Health Information Hub, 2020). In the
practice chosen for this scholarly project, the primary care provider had noticed a continuous
increase in HbA1c values despite medication and educational interventions. The provider
communicated to the project leader the difficulties he experienced daily due to the rural location
of his clinic, including the inability to refer patients to specialty providers (i.e., endocrinologists,
dieticians), provide adequate education, and provide management therapies. Due to these
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reasons and common barriers, the purpose of this project was to create an HL-specific
educational pamphlet with an SMS reinforcement tool that could be easily implemented in a
rurally located primary care clinic. The goal of this project was to improve self-efficacy and
glycemic control in T2DM patients with limited and low HL.
Team formation. Step 3 of the Iowa Model is the formation of a team. The project team
leader began by identifying primary stakeholders, which included the project scholarly chair, the
location for the project, and a primary care provider. The project team leader and the project
chair communicated and collaborated to establish clear roles, guidelines, and recommendations
for each stakeholder throughout the completion of the project. The project team for this
scholarly project included the project team leader, the scholarly project chair, the primary care
provider (a certified physician assistant), three nurses, three medical assistants, and one front
desk ancillary staff member.
Assemble, appraisal and synthesis of evidence. Once the topic of interest was selected
and the project team was established, the next step was to assemble, appraise, and synthesize the
body of evidence (Iowa Model Collaborative, 2017). Step 4 included conducting a systematic
review and evaluating the evidence, addressing the quality and strength of each research article
(Doody & Doody, 2011; Iowa Model Collaborative, 2017). The team leader examined 15
articles for this scholarly project; each article was graded using Melnyk’s levels of evidence.
Melnyk’s pyramid system of hierarchy contains six levels: the lower the number, the higher
grade the evidence is. The literature review for this scholarly project contained Levels I, III, IV,
and VI evidence. Level I evidence included a systematic review and RCTs examining the
utilization of HL tools and mobile technology applications to improve self-efficacy and glycemic
control in patients with T2DM. Level III evidence articles included two short-term, quasi-
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experimental studies. Level IV evidence articles included five cross-sectional studies that
evaluated the relationship between self-efficacy, self-care behaviors, and glycemic control
among T2DM patients. The Level VI evidence article was a nonexperimental descriptive survey
that supported the existence of poor disease management and moderate self-efficacy levels in
patients with T2DM. As evidence was found supporting glycemic control improvements, patient
adherence, and self-efficacy confidence, this systemic review was proven successful to support
the project leader in an EBP project. This literature review reinforced the use of tailored DM
education, automated text messages, and diabetes educational programs in rural locations.
Developing an evidence-based practice standard. To create a set of practice standards,
guidelines, and treatment options, the project leader developed a two-part intervention using
information gained from the literature review. Conclusive evidence supported the utilization of
tailored DM educational materials, mobile technology, and automated text messages for
improving diabetes knowledge, self-efficacy, and glycemic control in T2DM patients.
Although positive evidence was discovered in an abundance regarding the identified
themes, the project leader was unable to find literature combining the utilization of tailored DM
educational materials for low-HL patients and automated text messages. Two critical
components for patient adherence and disease management are diabetes education and
identifying an individual’s HL level. Therefore, the project leader utilized these two essential
components to develop a two-part intervention: the first an HL-specific educational pamphlet,
the second a text message reinforcement tool.
Patients with T2DM can benefit instrumentally from education programs when they are
tailored to their learning style, preference, and HL level (Koonce et al., 2015). T2DM is a
chronic, self-limiting disease requiring patients to perform approximately 95% of their
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independent daily self-management behaviors. Self-efficacy and self-management behaviors are
positively associated with patient adherence and glycemic control improvements (Abaza &
Marschollek, 2017; Amer et al., 2018; Bohyun et al., 2019). However, evidence concluded
patients living in rural locations often have poor disease management skills and moderate selfefficacy levels (Gedik & Kocoglu, 2018). Therefore, an HL-specific educational intervention
was created for the limited- and low-HL patient with T2DM. The project leader created the
educational intervention using resources from the ADA, the Centers for Disease Control and
Prevention, the NIDDK, the Diabetes Plate method, and several diabetes specialty providers.
Living in an era of continuously evolving technology, the project leader evaluated the use
of mobile technology and automated text message use. Mobile applications and standard text
messaging have been shown to produce favorable outcomes when utilized with T2DM patients.
Research has found a reduction in HbA1c values and an increase in positive self-management
behaviors, including prescription adherence, physical activity, and diet compliance when mobile
applications and text messaging are used (Abaza & Marschollek, 2017; Fioravanti et al., 2015;
Lari et al., 2018; Nelson et al., 2016). Given the clear associations between mobile technology
and favorable outcomes for patients with T2DM, the project leader designed an SMS
reinforcement tool as a second part of the EBP project. Using information from the HL-specific
educational diabetes pamphlet, the project leader created 12 “pop quiz” questions. Every Friday
at 10:30 a.m. during the implementation phase, enrolled participants received a pop quiz
question. The purpose of the weekly pop quiz was to reinforce an educational environment for
the limited- and low-HL patient with T2DM.
The project leader designed a combination therapy for limited- and low-HL patients with
T2DM with intent to improve self-efficacy and glycemic control. Patients who reside in low-
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income and rural areas often lack access to proper health care, specialty providers, diet
management, physical activity, and transportation. One in five Americans is classified as having
limited or low HL skills, whereas one in three Americans with T2DM has limited or low HL
(Abdullah et al., 2019; U.S. Department of Education, 2019). The purpose of this scholarly
project was to create an educational pamphlet tailored to the learning style, preference, and low
HL level of the average T2DM patient. This scholarly project aimed to increase a patient’s
diabetes knowledge and HL level to improve self-efficacy, self-management behaviors, and
glycemic control.
Implementation of the evidence-based practice standard. After the scholarly project
was designed, Institutional Review Board (IRB) approval was granted on January 20, 2020. The
project leader then began meeting with the primary stakeholders to discuss project details and
begin advertising. Advertisement flyers were posted two months prior to the commencement of
the intervention phase (see Appendix G).
The project team leader aimed to recruit 30 participants; therefore, to gain interest from
established patients, the primary care provider compiled a list of all patients with DM for the
team leader. The project leader mailed each potential candidate a patient recruitment form (see
Appendix I) explaining the purpose of the project, participant requirements, and potential prizes
for participation. The participant recruitment form included the enrollment eligibility
questionnaire (see Appendix J). Participants were provided a pre-stamped envelope with
instructions to return the completed form if interested by February 28, 2020, allowing them one
month to complete the task.
The scholarly project was divided into three phases: pre-intervention, intervention, and
post-intervention. During the pre- and post-intervention phases, each eligible participant met
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with the project leader for an allotted time. All participants completed a consent form, an
enrollment eligibility form, and several questionnaires pertaining to self-efficacy and HL.
During the pre-intervention visit, each participant was provided the HL-specific DM educational
pamphlet and instructions for the SMS reinforcement tool. Additional measurements collected
during the pre- and post-intervention phases included blood pressure, weight, and an HbA1c
sample.
Phase two, implementation of the scholarly project, began March 16, 2020, and
concluded June 18, 2020. During the three-month intervention phase, each participant received
two daily text messages and one weekly pop quiz question. The daily text messages were
removed after week three. Twelve pop quiz questions were generated from the HL-specific DM
educational handout. Questions were sent to each participant every Friday morning at 10:30 a.m.
All text message data were recorded and stored in Microsoft Excel.
At the conclusion of this scholarly project, the three participants with the greatest
improvement scores in self-efficacy, HL, HbA1c values, and SMS involvement received prizes.
The grand prize winner received a 40-inch Onn. Roku FHD smart television. The follow-up
winner received a Fire HD Amazon tablet, while the third overall winner, received a pair of
wireless Bluetooth Skull headphones. The purpose of this scholarly project was to combine two
evidence-proven methods, mobile technology and tailored educational materials, into one
intervention to improve self-efficacy and glycemic control in the low-HL patient with T2DM.
Evaluation. All data collected during the three-month time frame were stored in
Microsoft Excel and analyzed utilizing the Statistical Package for the Social Sciences (SPSS)
software program, version 25.0. Outcome data were analyzed and evaluated using descriptive
statistics. Project data from the three-month pre-intervention period found that participants with
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lower educational levels, compared to those with an education level of some college (no degree),
had higher HbA1c control values and lower self-efficacy confidence scores. Additionally,
baseline HL values were correlated with lower educational levels. Post-intervention data
analysis identified an increase in self-efficacy confidence and HL knowledge and a reduction in
HbA1c values. Secondary evaluations included change in participant weight and blood pressure
values between pre- and post-intervention comparison data. The greatest individual
improvements witnessed during the three-month intervention were a 1.9% HbA1c reduction, a
12-pound weight loss, and an 18.75% increase in a self-efficacy confidence level.
When utilized and implemented correctly, diabetes self-management education tools can
improve diabetes knowledge, skills, and patient adherence (Russell, Vess, Durham, & Johnson,
2016). The findings from this scholarly project demonstrate the successful application of
diabetes self-management education tools. Therefore, EBP research should be evaluated further
among patients with low HL and the increasing prevalence of T2DM.
Theoretical Framework
Developed in 1984 by Prochaska and DiClemente, the transtheoretical model of behavior
change, also known as the stages of change model, was utilized for the theoretical framework (as
cited in White et al., 2016). The original linear model consisted of four stages:
precontemplation, contemplation, preparation, and action. In 1986, the model became a cyclic
process when a fifth stage was added, the maintenance phase (White et al., 2016). To predict
and move through the stages of change model, 10 processes of change were created in 1992 by
Prochaska, DiClemente, and Norcross (as cited in White et al., 2016). The transtheoretical
model has been successfully used to improve adherence in patients receiving counseling for HIV
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therapy, antihypertensive medication treatment, smoking cessation, and T2DM medication
adherence (Arafat et al., 2019; White et al., 2016).
Self-efficacy and self-management behaviors have been identified as two of the most
common reasons for uncontrolled T2DM; therefore, due to the behavioral nature of acceptance,
the transtheoretical model was selected for this scholarly project. The transtheoretical model
aids individuals at every stage of readiness (Ruggiero, 2000). The purpose of this chosen model
was to identify the current level of readiness of an individual and select their health care
interventions accordingly (Ruggiero, 2000). This method provides motivation for the patient
who is ready to take control of their HbA1c value (action) but also provides autonomy for the
individual who is about to make a change (preparation for action). Proven to increase patient
satisfaction and patient outcomes, the chosen framework provided support and guidance
throughout the scholarly project phases.
Summary
The purpose of the literature review was to provide compelling evidence to support the
importance of self-efficacy and self-management behaviors in patients with T2DM. Through the
literature review, evidence reflected the importance of two key interventions: the utilization of
technological advancements and tailored educational materials for T2DM patients. The
utilization of technological advancements such as mobile applications and SMS interventions
improve glycemic control, patient adherence, self-efficacy, and self-management behaviors
(Abaza & Marschollek, 2017; Fioravanti et al., 2015; Nelson et al., 2016). Similarly, tailored
educational materials, such as DM and self-management tools, enabled patients to avoid
complications by managing and controlling their diseases more efficiently (Abaza &
Marschollek, 2017; Koonce et al., 2015).
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Research studies demonstrated that HL is a critical component of patient adherence and
disease management, yet minimal research has combined the two elements. Approximately 33%
of all patients with T2DM are classified as having low HL, yet despite the evolution of
technology, research implies SMS applications for educational use are lacking (Abaza &
Marschollek, 2017; Abdullah et al., 2019). Considering the importance of HL in DM
management and patient awareness, an intervention combining mobile technology and HLspecific education was vital for patient success.
Therefore, the purpose of this scholarly project was to utilize an HL-specific educational
intervention combined with a SMS reinforcement tool to improve glycemic control and selfefficacy in patients with T2DM. The combination therapy intervention reinforced initial diabetes
teaching by providing participants an easy and convenient method to improve their diabetes
knowledge and education and therefore increase their self-efficacy confidence, improve their
HL, and improve their overall glycemic values.
SECTION THREE: METHODOLOGY
The purpose of this scholarly project was to identify if the utilization of an HL-specific
DM educational pamphlet, when combined with an SMS intervention, would increase selfefficacy and glycemic control in a T2DM patient with limited or low HL. The project utilized a
descriptive, quasi-experimental design to evaluate the association between patients with T2DM
and HL. A convenience sample of four T2DM patients was utilized in this project. Participants
were recruited from a rurally located, private primary care office located in the Piedmont region
of North Carolina. The aim of this scholarly project was to utilize mobile technology and
tailored DM educational materials to improve self-efficacy and glycemic control in the low-HL
T2DM patient over a three-month timeframe.
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Design
The Iowa Model was used as the conceptual framework in the step-by-step guided
analysis, and the design for this scholarly project was an EBP model. A quasi-experimental,
pilot intervention was conducted at a privately-owned physician’s office in the Piedmont region
of North Carolina. The goal of this scholarly project was to improve self-efficacy and HL while
reducing HbA1c values in the low-HL patient with T2DM. Two months prior to the
implementation of this scholarly project, advertisement flyers were posted. The project team
leader aimed to recruit 30 participants; however, out of the 17 responses received, six met
inclusion criteria, and only four completed the pre- and post-intervention questionnaires. For a
baseline evaluation and a post-intervention data comparison analysis, the project team leader met
with each eligible participant for 45 minutes pre-intervention and 30 minutes post-intervention.
During the scheduled office visits (pre- and post-intervention), the project leader collected
enrollment eligibility questionnaires, demographic forms, and study questionnaires (the SelfEfficacy for Diabetes Likert questionnaire and the Newest Vital Sign [NVS] were used).
Secondary data collected during the scheduled office visits included blood pressure, weight, and
an HbA1c sample. During the pre-intervention office visit, each project participant received the
HL-specific DM educational pamphlet, in addition to text message usage instructions, including
a trial text message with the project leader. During the three-month intervention, each project
participant received two daily text messages and one weekly pop quiz text message. Daily text
messages included “Did you take your blood sugar medicine?” and “Did you check your blood
sugar?” were sent at 10:00 a.m. and 10:15 a.m., respectively; these text messages were removed
from the intervention after Week 3. The weekly pop quiz question was sent every Friday
morning at 10:30 for 12 weeks.
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Measurable Outcomes
Outcome 1. After the completion of this evidence-based intervention, T2DM patients
with low HL would demonstrate an improvement in self-efficacy confidence. This outcome
would be evidenced by an increase in all self-efficacy Likert scores on the Self-Efficacy for
Diabetes post-questionnaire when compared to the pre-questionnaire.
Outcome 2. At the completion of this evidence-based intervention, T2DM patients with
low HL would demonstrate an increase in HL scores. This outcome would be evidenced by an
increase in the total value score on the NVS tool on the post-assessment when compared to the
pre-assessment.
Outcome 3. At the completion of this evidence-based intervention, patients would
demonstration a reduction in HbA1c values. This outcome would be evidenced by comparing
HbA1c values drawn pre- and post-educational intervention implementation.
Setting
This scholarly project was conducted at a small, privately owned, family medical practice
located in the Piedmont region of North Carolina. The estimated population of the Piedmont
region is 142,088 (U.S. Census Bureau, 2019). The majority of the residents of the region are
White (79.4%), while 16.9% are Black or African American, 9.4% are Hispanic or Latino, and
less than 2% are Native Hawaiian, Asian, American Indian, Alaskan Native, or two or more
races (U.S. Census Bureau, 2019). The median age is 40 years (13%); majority of the residents
are between 18 and 64 years; 85.3% of persons 25 years and older have a high school diploma,
while only 18.7% have a bachelor’s degree or higher (U.S. Census Bureau, 2019). The National
Health Literacy Mapping to Inform Health Care Policy (University of North Carolina at Chapel
Hill, 2014), indicates the county where the practice is located is listed among the lowest quartile
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for HL in North Carolina. The median household income is $48,667; the percentage of persons
living in poverty is 16.3% (North Carolina Department of Commerce, 2019).
The selected health care facility was chosen for this scholarly project due to the rural
location and interprofessional collaborative support offered by the medical practice. The private
family practice is a patient-centered medical home. Identified as a care delivery model, a
patient-centered medical home ensures patients receive the necessary care and treatment they
need when they need it (American College of Physicians, 2019). With over 20 years’
experience, the primary care provider of the selected location provides general services,
prevention and wellness screening, physical examinations, chronic care, and disease
management services. The location has co-management agreements with a mental health facility
and an urgent care office, which provide behavioral health and urgent care services. Located in a
rural area with a high level of low HL and a high disease prevalence of T2DM, the family
practice was an ideal location for this scholarly project. This scholarly project aimed to
implement an HL-specific DM educational pamphlet that would improve self-efficacy and
glycemic control over a three-month time frame. The primary care provider of the office
provided a letter of support for the scholarly project to take place at the chosen site (see
Appendix E).
Population and Sample
The project included a convenience, purposeful sample of T2DM patients with limited
and low HL. The project team leader aimed to recruit 30 participants. However, out of the 17
responses received, six met inclusion criteria, and only four completed the pre- and postintervention analysis measurements. Participants in the scholarly project were required to have a
health care diagnosis of T2DM for a least a one-year duration, be 18 years of age or older, have
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access to a mobile device, be able to read, write, and speak in English, and have an associate’s
degree or less in education. Exclusion criteria were any DM diagnosis other than T2DM
(T1DM, gestational), being non-English speaking, or having an education level greater than an
associate’s degree (i.e., bachelor’s or higher).
Ethical Considerations
The Doctor of Nursing Practice project team, including the project team leader and the
project chair, completed extensive research ethics training to ensure protection of human
subjects. This research training was completed through the Collaborative Institutional Training
Initiative; a certificate was awarded for completion (see Appendix D). To ensure all ethical
considerations and standards for research involving human subjects were met throughout the
implementation and duration of this scholarly project, an approval was granted by the IRB of
Liberty University on January 20, 2020 (see Appendix B).
Ethical considerations addressed included patient consent, protection of human subjects,
and data confidentiality. During the first encounter with each participant, the project team leader
obtained an informed consent signature from each participant for their participation in the
scholarly project (see Appendix F). A copy of the informed consent document was provided to
each participant. Per the informed consent, personal information would only be shared with the
project team chair. To ensure confidentiality, each project participant was assigned a coded
number and letter for data collection. All personal information collected through questionnaires
and text messaging was encrypted through data codes, protected, and stored in Microsoft Excel
on a password protected laptop.
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Data Collection
Data collection tools for this scholarly project included an enrollment eligibility
questionnaire, a patient demographic evaluation, a self-efficacy Likert-ranking questionnaire,
and an HL questionnaire. Excluding the enrollment questionnaire and the patient demographic
evaluation, all pre-data intervention components were re-collected post-implementation. The
enrollment eligibility questionnaire required participants to provide their date of birth, highest
level of completed education, diabetes diagnosis, access to a mobile device (with text messaging
capabilities), and ability to read, write, and speak the English language (see Appendix J). The
patient demographic evaluation provided the participant’s date of birth, gender, and
race/ethnicity (see Appendix K). The project team leader collected all enrollment eligibility and
demographic questionnaires. Pre- and post-intervention, each participant’s blood pressure,
weight, and HbA1c were collected. Blood samples for the pre- and post-HbA1c evaluation were
collected by the clinic staff in a secured, clean environment. Once collected, the samples were
transported to Quest Diagnostics for evaluation, and results were delivered within 24–48 hours.
The project team leader was provided the resulted HbA1c values from direct staff at the primary
care clinic for each participant. All text messaging activity completed by each study participant
was recorded in Microsoft Excel for data collection and analysis.
Tools
To evaluate self-efficacy and HL of patients with T2DM, several tools were utilized for
this scholarly project. The Self-Efficacy for Diabetes scale and the NVS tool were used during
the pre- and post-intervention segments. Permissions were not needed for the use of the SelfEfficacy for Diabetes scale (Self-Management Resource Center, 2020) nor the NVS tool (Weiss,
2018).
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To evaluate self-efficacy in patients with T2DM, the Self-Efficacy for Diabetes Likert
questionnaire tool was used. This eight-question tool was originally created and tested in
Spanish for the evaluation of diabetes self-management (Self-Management Resource Center,
2019). The Self-Efficacy tool is a 10-item Likert scale which aims to identify how confident an
individual is in completing certain activities or tasks. A score of 1 represents not confident at all,
and a score of 10 indicates “totally confident;” the mean of all eight items provides the total
score. A higher score indicates higher self-efficacy (Self-Management Resource Center, 2019).
The NVS was used to identify each participant’s HL level. To administer the NVS, the
project team leader provided each participant an ice cream label and asked them six questions.
The NVS was to be completed in two to three minutes and required the test taker to perform
simple mathematical equations and interpret basic text (Weiss, 2018). The participant could ask
for paper, writing devices, or to use a calculator; however, these things were not allowed to be
offered up front (Weiss, 2018). For each correct response, one point was rewarded for a
maximum score of six. A score of 0-1 was highly suggestive of limited HL (50%), 2-3 indicated
a possibility of limited HL, and a score of 4-6 indicated adequate HL (Pfizer, 2019; Weiss,
2018).
As evidenced by the extensive literature review, automated text messages and mobile
technology education applications have proven to be effective for improving medication
adherence, self-efficacy, self-management behaviors, and glycemic control (Abaza &
Marschollek, 2017; Fioravanti et al., 2015; Lari et al., 2018; Nelson et al., 2016). That being so,
to reinforce learning, an automated text message was sent to every participant. In the beginning,
the project leader sent each participant two reinforcement text messages daily and one weekly
pop quiz question. After Week 3, the daily text messages were discontinued. The initial daily
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text messages were sent at 10:00 a.m. asking, “Did you check your blood sugar,” and at 10:15
a.m. asking, “Did you take your blood sugar medication?” Each participant replied with a (1) for
yes or a (2) for no. The weekly pop quiz question was sent every Friday morning at 10:30 a.m.
Twelve questions were created from the HL educational pamphlet for a total of 12 weeks (see
Appendix L). The participant received a question with answer choices 1 through 4. If the
participant replied with the correct answer, a follow-up text message would be sent such as “Way
to go!” If the participant answered incorrectly, an encouraging statement such as “Better luck
next time,” or “You almost had it,” followed by a short text message with the correct answer and
page number for reference was sent.
During the pre-intervention encounter, the project team leader provided all participants
with a text message instruction guide for reference, and a trial text message was exchanged
between the project leader and participant (see Appendix M). Weekly text messaging activity
was collected and stored in Microsoft Excel on a password-protected computer.
Intervention
The first part of the intervention was the creation of the HL-specific DM educational
pamphlet. The project leader chose to concentrate on four specific areas for education purposes:
T2DM education, disease management, dietary recommendations, and exercise considerations.
T2DM education and disease management included a disease overview, T2DM causes,
prevention measures, normal and abnormal blood sugar values, and what to do when one’s blood
sugar is too high or too low. Dietary recommendations included nutrition suggestions, the
Diabetes Plate Method, instructions for measuring food portions, and information on how to
interpret a nutrition label. Exercise and physical activity considerations included recommended
goals per week with examples, types of exercises, and safety tips. To ensure information was
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correct and up to date, the project leader used accredited resources from the ADA, the Centers
for Disease Control and Prevention, the NIDDK, and several diabetes specialty providers; no
information was more than two years old.
To create this easy-to-read handout, the project leader had to consider the target audience
and goals of the document. The target audience for this pamphlet was low-HL patients with
T2DM; therefore, education information was written at or below the eighth-grade level
(MedlinePlus, 2019). Information was written in plain, simple English; all medical jargon,
complex wording, abbreviations, and abstract language was avoided. Additional considerations
used by the project leader during the creation of the documentation were illustrations, bright
colors, bold headings, and simplified fonts (MedlinePlus, 2019). The HL educational pamphlet
included an eight-page spread, each page presenting different content. Page 1 contained the title
of the scholarly project and the name of the project leader, Page 2 included participant name,
month, date, and a blood sugar tracker for the three-month timeframe, and Page 3 presented a
colorful nutrition label with instructions on how to interpret it and helpful diabetes tips. Page 4
contained the diabetes Plate Method with colorful pictures and examples for each category, Page
5 provided instructions on how to measure food using portion sizing with examples compared to
one’s hand and familiar items (e.g., deck of cards), and Pages 6 and 7 presented insightful
diabetes tips including information on normal/abnormal blood sugar values, treatment for
abnormal blood sugar values, nutrition, and exercise recommendations, and Page 8 provided the
references utilized in the making of the educational pamphlet.
The second part of the scholarly project intervention was the creation of the SMS
reinforcement tool. Also utilized as a data collection measure, the SMS reinforcement tool was
used to send each participant two daily text messages and one weekly pop quiz question. The
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daily text messages were removed after two weeks for reasons to be explained in the results and
discussion sections. Twelve weekly pop quiz questions were created from the HL-specific DM
educational intervention.
The project team leader met with each participant during a scheduled 45-minute time slot
for the pre-intervention data collection phase. During this time, the team leader collected
consent forms, enrollment eligibility forms, demographic questionnaires, pre-intervention
questionnaires (the eight-question Self-Efficacy for Diabetes scale and six-question HL
assessment), blood pressure, weight, and an HbA1c sample. Each participant was provided with
the HL DM educational pamphlet and instructions for the SMS reinforcement tool (see Appendix
M). During this time, all participant questions were answered, a trial text message was
exchanged between each participant and the project team leader to ensure adequate
understanding, and a follow-up meeting was scheduled between the participant and the team
leader for June 18, 2020 (post-intervention). This scholarly project was implemented from
March 16 to June 18, 2020, a three-month period. During the intervention phase, all SMS data
collected were stored in Microsoft Excel.
At the conclusion of this project, all participants returned to the clinic to meet with the
project team leader during a scheduled 30-minute appointment. During this time, each
participant completed the same questionnaires as at the pre-intervention meeting, the eightquestion Self-Efficacy for Diabetes Likert questionnaire and the six-question HL assessment.
An HbA1c sample was collected in addition to the participant’s blood pressure and weight. At
the completion of the scholarly project, the project leader analyzed the data collected from each
phase; an evaluation was completed, and the results were disseminated. Three individuals were
rewarded grand prizes were based upon highest improvement scores in self-efficacy and HL,
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reduction in HbA1c, and involvement in text messages over the three-month intervention. All
participants who completed the scholarly project for the three-month duration were sent a thank
you letter and a $5.00 Walmart gift card.
Timeline
The project team leader spent approximately one year completing this project. The
timeline for this scholarly project was divided between four phases: (1) planning; (2) preimplementation; (3) implementation; and (4) evaluation. A detailed timeline for each phase with
activities and completion dates can be found in Appendix N.
Feasibility Analysis
To ensure the most cost-effective methods were utilized, the project team leader
completed a feasibility analysis to evaluate office personnel, resources, technology, and strict
budgeting. The office personnel were paid directly though the clinic; the only interactions staff
had with the project participants were during the pre- and post-intervention evaluations and for
acute visits (if needed). All supplies needed to collect the pre- and post-intervention HbA1c
samples were provided by the clinic and processed through Quest Diagnostics.
The HL educational pamphlet was created by the project team leader using free
resources. The educational pamphlet and advertisement flyers were printed by the project team
leader. Text messages sent during the three-month intervention were sent from the project team
leader’s personal cellular device. Project participants were not required to download a mobile
device application. All participants were informed no additional charges would be charged to
their mobile device, other than standard text messaging data charges, as specific in the consent
form.
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The three grand prizes for this scholarly project were a 40-inch Onn. Roku FHD smart
television purchased for $100.00, a Fire 7 HD Amazon tablet purchased for $29.99, and a pair of
wireless Bluetooth Skull headphones purchased for $19.99. All participants received a $5.00
Walmart gift card for a total of $20.00. The total financial cost for this scholarly project was
$170.00, which, when compared to chronic DM treatment and direct medical costs, is relatively
reasonable.
Data Analysis
To evaluate each of the project’s measurable outcomes, data were collected during each
phase of the scholarly project. Utilizing SPSS software and descriptive statistics, pre- and postintervention data analysis were performed for each measurable outcome. Post-intervention data
were compared to pre-intervention data to determine if a significant difference had occurred in
participant self-efficacy confidence, HL scores, and HbA1c values. Additional measurements
included a comparison of pre- and post-intervention blood pressure and weight. Text messaging
data collected during the three-month intervention phase were stored in Microsoft Excel. A data
analysis was completed identifying user responses’ and text message frequency.
Outcome 1. At the completion of this evidence-based intervention, T2DM patients with
low HL would demonstrate an improvement in self-efficacy confidence. This outcome was
evidenced by an increase in self-efficacy Likert scores. Descriptive statistics compared pre- and
post-intervention scores from the Self-Efficacy for Diabetes pre- and post-questionnaires.
Outcome 2. At the completion of this evidence-based intervention, T2DM patients with
low HL would demonstrate an increase in HL scores. This outcome was evidenced by a
substantial increase in the total average value score on the NVS assessment. Descriptive
statistics compared pre- and post-intervention values.
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Outcome 3. At the completion of this evidence-based intervention, patients would
demonstrate a reduction in HbA1c values. This outcome was evidenced by a comparison of
HbA1c values drawn pre- and post-combination therapy intervention.
SECTION FOUR: RESULTS
The project leader acquired 17 responses using the patient recruitment form (Appendix I);
of those, six individuals met inclusion criteria. Only four participants completed the enrollment
eligibility form (Appendix J), consent form (Appendix F), demographic questionnaire (Appendix
K), Self-Efficacy for Diabetes scale (Self-Management Resource Center, 2020), and NVS
evaluation tool (Weiss, 2018), and had the required miscellaneous procedures completed (blood
pressure, weight, and blood sample for HbA1c) pre- and post-intervention evaluation. One of
the three total project participants requested to be removed from the SMS intervention portion
for personal reasons; however, the patient completed all pre- and post-intervention data analysis
measures.
The utilization of a combination therapy for T2DM patients with limited or low HL
demonstrated positive results with improving self-efficacy confidence, HL values, and glycemic
control. This scholarly project yielded the following demographics. The four participants had an
average mean age of 63 years. Minimum participant age was 49 years, and maximum participant
age was 78 years. See Table 1 for project participants’ gender characteristics, ethnicities, and
highest levels of completed education.
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Table 1
Participant Demographics
Demographic
Gender
Male
Ethnicity
Caucasian or White
Hispanic
Education level
Less than high school
High school diploma or GED
Some college, no degree
Note. N = 4.

n

Percent

4

100

3
1

75
25

1
1
2

25
25
50

The project leader sent two daily text messages at 10:00 a.m. and 10:15 a.m. followed by
a weekly pop quiz question every Friday at 10:30 a.m. After two weeks, one project participant
requested to be removed from the SMS intervention portion. The project leader continued the
daily text messages with the other participants for one additional week. After three weeks, a
continuous response trend was identified among the remaining participants; for that reason, the
daily text messages were discontinued. Of the remaining three participants, two responded
100% of the time (12/12), and one responded 92% of the time (11/12). For the weekly pop quiz
questions, two participants answered correctly 100% of the time (12/12), and one participant
answered correctly 42% of the time (5/12). Evidence identified a correlation between participant
response and overall improvement; individuals who responded more often experienced superior
improvements when compared to those who did not.
Evidence reflected individuals with an educational level of some college (no degree) had
lower HbA1c control values and higher baseline self-efficacy confidence values when compared
to those with lower education levels (see Table 2). These results demonstrated that lower
participant educational levels were associated with lower baseline HL scores. Limited or low
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HL knowledge was associated with poor self-efficacy confidence, poor disease management
skills, and poor glycemic control, which are directly and indirectly associated with T2DM
complications and increased mortality rates.
Table 2
Highest Level of Completed Education and Average Self-Efficacy Confidence and HbA1c
Education level
Less than high school
High school diploma or GED
Some college, no degree
Note. N = 4.

n
1
1
2

Mean self-efficacy confidence
55
68
70

Mean HbA1c (%)
10.5
12.6
7.3

Descriptive Statistics
The HL-specific DM educational pamphlet combined with the SMS intervention
demonstrated positive results with improving self-efficacy confidence, HL knowledge, and
glycemic control in limited- or low-HL patients with T2DM over the three-month timeframe. A
9% overall increase in self-efficacy confidence levels was found based on the Self-Efficacy for
Diabetes Likert questionnaire. Before the intervention, the average number of correct answer
choices on the NVS was 3 out of 6, and the total sum for all participants was 12 out of 24 (50%).
After the three-month combination therapy intervention, the mean value of correct answers
increased to 5.5 (+2.5) and the total sum statistic increased to 22 (92%), a 42% overall increase.
The initial mean HbA1c pre-intervention was 9.4% and post-intervention was 8.9%, creating a
0.5% mean reduction.
Measurable Outcome 1
After the completion of this evidence-based intervention, T2DM patients with low HL
were expected to demonstrate an improvement in self-efficacy confidence. This goal was met, as
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evidenced by an overall 9% average increase in the self-efficacy Likert scores on the SelfEfficacy for Diabetes questionnaire (see Table 3).
Table 3
Self-Efficacy Confidence Pre- and Post-Intervention Data Analysis Measures
Percentage
Confidence Minimum Maximum
Sum
Total
of select
Mean
SD
level
statistic
statistic
statistic statistic categories statistic statistic
Pre55
80
263
320
82
65.75
10.905
intervention
Post59
80
292
320
91
73.00
9.557
intervention
Difference
+9
Note. N = 4. SD = standard deviation. Min/max = minimum self-efficacy confidence
level/maximum self-efficacy confidence level. Sum statistic = total participant self-efficacy
value, total statistic = total self-efficacy value, percentage = sum statistic/total statistic,
difference = pre- and post-combination therapy intervention.
Measurable Outcome 2
After the completion of this three-month evidence-based intervention, T2DM patients
with low HL were expected to demonstrate an increase in HL scores. The most significant
accomplishment of this study was the overall 42% average improvement in the HL scores of the
participants. The average number of correct answers increased overall by 2.5. The lowest
number of correct answers pre-intervention was two of six, and the highest was four; postintervention, the lowest number of correct answers was four, and the highest was six (maximum
score). The outcomes of this goal were calculated by comparing the pre- and post-intervention
HL score values for each participant (see Table 4).
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Table 4
Pre- and Post-Intervention Health Literacy Data Analysis Measures
Percentage
of select
categories
50

Literacy
Minimum Maximum
Sum
Total
Mean
SD
value
statistic
statistic
statistic statistic
statistic statistic
Pre2
4
12
24
3.0
1.155
intervention
Post4
6
22
24
92
5.5
1.000
intervention
Difference
+42
+2.5
Note. N = 4. SD = standard deviation. Min/max = minimum self-efficacy literacy
value/maximum self-efficacy literacy value. Sum statistic = total participant literacy value. Total
statistic = total literacy value. Percentage = sum statistic/total statistic. Difference = pre- and
post-combination therapy intervention.
Measurable Outcome 3
After the completion of this evidence-based intervention, it was expected that patients
would demonstrate a reduction in HbA1c values. The highest HbA1c value collected during the
pre-intervention phase was 12.6%; the participants’ mean HbA1c value was 9.4%. Post threemonth combination implementation therapy, the highest HbA1c value collected was 10.7%; the
participants’ mean value HbA1c was 8.9%. Therefore, there was a 0.5% mean value reduction.
The greatest HbA1c reduction value over the three-month combination therapy intervention was
1.9% (see Table 5).
Table 5
HbA1c Pre- and Post-Intervention Data Analysis Measures
HbA1c
Minimum HbA1c (%) Maximum HbA1c (%) Group mean (%)
SD
Pre-intervention
7.0
12.6
9.425
2.6107
Post-intervention
6.2
10.7
8.900
2.0928
Difference
+0.525
Note. N = 4. Min/max HbA1c = minimum hemoglobin A1c/maximum hemoglobin A1c.
Difference = pre- and post-combination therapy intervention
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Short Message Service
At the completion of this three-month combination intervention therapy, the project
leader evaluated the association between participant outcomes and SMS interactions. Although a
positive association was evident between participant response and individual improvement, it is
difficult to determine if the text messages made a significant difference in the overall outcome of
the scholarly project. Two of the four participants indicated they felt the weekly text messages
were helpful and beneficial with learning their diet and exercise recommendations. One
participant stated, “I looked forward to my pop quiz every Friday morning just so I could prove
to my wife what I had learned.” Three of four participants interacted weekly for the duration of
the scholarly project. When compared to pre-intervention data analysis, two participants
reflected remarkable improvements with self-efficacy confidence, HL knowledge, and glycemic
control. The third participant displayed improvements with HL knowledge, blood pressure, and
weight loss.
SECTION FIVE: DISCUSSION
This quasi-experimental study sought to identify if an HL-specific combination therapy,
compared to standard DM education, could improve self-efficacy and glycemic control in
patients with T2DM over a short time frame. The findings of this project support and further
clarify results of the small body of research regarding tailored education for improving DM
patient outcomes. Key findings of this scholarly project included an increase in self-efficacy
confidence, an increase in HL knowledge, and a decrease in HbA1c values. Additional
encouraging findings include weight loss, blood pressure reduction values, and positive
participant feedback. The results of this scholarly project indicate an HL-specific combination

COMBINATION THERAPY FOR TYPE TWO DIABETES MELLITUS

48

therapy is an effective approach for improving self-efficacy, HL, and glycemic control in a
patient with T2DM and limited or low HL.
Implications for Practice
Based on the positive results of this scholarly project, it is safe to conclude that current
practice guidelines should consider this intervention or a similar approach for clinical practice.
Combination therapy is not a feasible approach for every health care clinic due to budgetary
constraints; however, the HL-specific DM educational pamphlet should be further evaluated for
consideration. This project can be easily replicated, implemented, and updated as necessary with
ADA guidelines. As evidenced by this project, the educational tool can promote disease
management, improve self-efficacy confidence, and improve disease knowledge. Recognized as
a global health threat, DM directly affects patients and their families while costing health care
systems billions of dollars annually. T2DM represents 90%–95% of all diabetes diagnoses, yet it
can be prevented and/or delayed through diet and exercise. This project, similar to other
published studies, supports the utilization of tailored educational materials for DM patients and
automated SMS, as well as the importance of self-efficacy and self-management behaviors for
improving patient longevity.
Implications for Research
While studies similar to the one conducted by Koonce et al. (2015) support these project
findings, additional studies would be effective in strengthening the evidence to support the
consistent use of tailored educational learning materials to improve diabetes knowledge.
Although this scholarly project was designed around patients with limited and low HL skills, the
positive results could be duplicated in other EBP projects. Therefore, further research utilizing

COMBINATION THERAPY FOR TYPE TWO DIABETES MELLITUS

49

the combination therapy should be explored on a larger scale with a broader DM demographic
sample.
Furthermore, a challenge or consideration for future research is participant recruitment,
including but not limited to time and advertisement. The project leader had a difficult time
recruiting participants for this project. Given the limited timeline, two months prior to the
implementation phase, advertisement flyers were posted, and patient recruitment letters were
mailed to the established patients of the medical clinic. The intended population for this study
was low-HL patients with T2DM. In regard to the low response rate, the probability that the
targeted population did not comprehend or read the material sent to them is very high, and this
issue hindered the overall recruitment process.
Although the scholarly project was a two-part combination intervention, it may not be as
effective or financially viable for some providers. However, the educational pamphlet is
provider friendly and cost-effective and would be easy to implement, replicate, and update as
necessary in any primary care office or outpatient facility that works directly with T2DM
patients. Therefore, a health care provider and/or facility looking to improve T2DM patient
outcomes should consider additional research on the utilization of tailored educational materials
for DM patients.
Limitations
Several limitations were identified during the course of this scholarly project. First, the
small convenience participant sample and the project setting were limitations. The sample was
all male and the setting was one local, rural primary care clinic. Secondly, due to time
constraints, the recruitment strategy was limited; therefore, the final participant sample was
minimal. To prevent and/or reduce attrition, the project leader provided all participants
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monetary prizes for their participation during the three-month study; however, this can serve as a
limitation. Additionally, project participants were required to read, write, and speak in the
English language, another limitation of the research. Two-way communication between
participants and the project leader for the SMS interventions was established through personal
cellular devices. A mobile group SMS technology tool was going to be used initially; however,
due to budgetary constraints, this was not plausible. This could serve as a limitation, although
the project leader informed all participants of the means of communication up front and
established reminders to ensure correct Microsoft data entry. The final limitation identified was
the lack of a professional relationship between the project leader and the established patients of
the primary care clinic. This served as a limitation due to the inability to gain trust from the
established population, despite positive collaboration with the provider and staff.
Sustainability
The sustainability of this project depends upon the primary care provider and nursing
staff of the primary care clinic. It is important to note, due to limited resources and funding, this
clinic does not currently utilize mobile technology applications. Therefore, even though this
project was designed as a combination therapy using both the educational pamphlet and an SMS
reinforcement tool, the continued use of the HL-specific DM educational pamphlet is dependent
upon the health care providers. This project and the positive results were shared with the clinic
provider and staff. This HL-specific DM educational pamphlet can be used with current and
newly diagnosed T2DM patients. Although the educational pamphlet is HL specific and eight
pages long, only four pages present core DM content regarding dietary recommendations,
disease management, and exercise considerations for patients with T2DM. This pamphlet takes
less than 15 minutes for a health care provider to read to a patient and can be integrated into
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routine chronic care visits. As recommended by the ADA, follow-up medical evaluation visits
for patients with DM should include nutrition counseling, information on self-management
behaviors, immunizations, and routine health maintenance screening, in addition to other
wellness components (ADA, 2019). To increase diabetes patient knowledge, the HL-specific
educational pamphlet can be used during routine follow-up visits, which can decrease the risk for
acute and chronic diabetes complications. To help maintain the positive outcomes of the project
and current participant success, the health care clinic providers will need to promote and
maintain current measures. Otherwise, the benefits of the project will degrade over time.
Dissemination Plan
This scholarly project reinforced the importance of utilizing a tailored combination
therapy for patients with T2DM and low HL. By designing a tailored educational DM pamphlet
and reinforcing it with an SMS intervention, this scholarly project effectively helped manage and
improve T2DM in patients of a rural primary care clinic. This project achieved three measurable
outcomes over the three-month intervention time frame: increased self-efficacy confidence,
increased HL knowledge, and decreased average glycemic value. Additional measurable
outcomes achieved during this project included weight reduction and blood pressure
improvements. These pilot findings were shared with the primary care provider, site manager,
and nursing staff. Based on submission recommendations and guidelines, the team leader is
developing a manuscript for the ADA Diabetes Care journal for publication. Manuscript
publication is an option for pilot results and findings to be shared with communities and other
health care professionals.
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Conclusion
Tailored DM education is an indispensable strategy for improving diabetes knowledge
and patient outcomes. Current literature supports the use of tailored diabetes education,
automated text messages, and mobile technology applications; however, combining these
methods had not been considered until this project nor consistently utilized on an individualized
basis. T2DM is a rapidly evolving disease, costing health care systems billions of dollars
annually. With a high diagnosis rate and a high mortality rate, DM was the seventh-leading
cause of death in 2017. Unlike other DM classifications, Type 2 can be prevented or delayed
through self-care management behaviors. Therefore, it is reasonable to conclude through
continued provider and staff enforcement, this scholarly project can continue to improve the
diabetes knowledge of T2DM patients who use this tailored educational approach. With
improved diabetes knowledge, patients can achieve self-efficacy confidence, self-management
behaviors, and glycemic control.
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Evidence Table
Article

Study
Purpose

Sample

Methods

Study Results

Abaza, H., &
Marschollek, M.
(2017). SMS
education for the
promotion of
diabetes selfmanagement in low
& middle income
countries: A pilot
randomized
controlled trial in
Egypt. BMC Public
Health, 17, 1–19.
doi:10.1186/s12889017-4973-5

To examine
the impact on
selfmanagement
behaviors and
glycemic
control, of
SMS
education
when
compared to
standard
paper-based
methods
among T2DM
patients in
Egypt

73 Total
participants
(English
speaking,
T2DM, 18yrs
and older)
-34
intervention
-39 Control

12-week
Randomized
control trial

Abdullah, A., Liew,
S. M., Salim, H., &
Chinna, K. (2019).
Prevalence of limited
health literacy among
patients with type 2
diabetes mellitus: A
systematic review.
PLoS One, 14(5),

To summarize
and report the
current
evidence on
the prevalence
of limited
health literacy
in patients
with type two

29 studies
involving
13,457
T2DM from
7 different
countries

Systematic
Review
Searching:M
EDLINE
PsychINFO,
EMBASE,
CINAHL,
and ERIC
published up

A clear
association
between the
intervention
group was
identified with
a 1% reduction
in HbA1c
values (p =
0.003);
knowledge
scores,
medication
adherence, and
self-efficacy
scores were
identified as
secondary
improvement
outcomes
Health literacy
tools and
prevalence of
health literacy
varied widely
among
differing
countries; In
the United

Melnyk
Level of
Evidence

Study
Limitations

Would Use as
Evidence to Support
a Change?

Level 2:
Welldesigned
RCT

Short time
frame (3
months), small
sample size;
therefore,
inability to
generalize
findings; lack
of incentives
to reduce
drop-out rate

Yes, this article does
provide significant
evidence to support
change in the
promotion of diabetes
self-management and
self-efficacy

Level 1:
Systematic
Review

No limitations
were
identified

Yes, this systematic
review provides
significant evidence to
support change in the
promotion of health
literacy interventions
and tools among
patients with type two
diabetes
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diabetes
globally and
the associated
factors

to January
2017

Amer, F. A.,
Mohamed, M. S.,
Elbur, A. I.,
Abdelaziz, S. I., &
Elrayah, Z. A.
(2018). Influence of
self-efficacy
management on
adherence to selfcare activities and
treatment outcome
among diabetes
mellitus type 2
Sudanese patients.
Pharmacy Practice
(1886-3655), 16(4),
1–7.
doi:10.18549/PharmP
ract.2018.04.1274
Bohyun K.,
Youngshin S., &
Jong, I. K. (2019).
Psychological insulin
resistance and low
self-efficacy as
barriers to diabetes
self-care
management in
patients with type 2
diabetes. Korean

To identify
the influence
of
management
self-efficacy
on adherence
to self-care
activities and
treatment
outcome
among
Sudanese
patients with
type two
diabetes

A
convenience
sample of
392 patients
two health
care facilities
in Sudan
from April to
May 2016

A crosssectional
study

To identify
the
association
among
diabetes selfefficacy,
psychological
insulin
resistance,
and diabetes
self-care

This study
was a part of
another
parent study,
Data
collection
from
December
2015 to
March 2016;
192 T2DM

A crosssectional
design

States, 1 in 3
patients with
type two
diabetes had
limited health
literacy
Self-efficacy
was
significantly
associated with
adherence to
glycemic
control and
self-care
activities; Selfefficacy was
associated with
receiving
health
education and
with high level
of education

Positive
correlation
between Selfcare
management
and diabetes
self-efficacy;
One should
consider
psychological
resistance and

Level 4:
CrossSectional
Study

Conducted in
only two
settings in one
state;
therefore,
inability to
generalize
sample;
convenient
sample; data
was collected
with a selfreported
method

Yes, this study is
helpful as it provides
sufficient evidence to
support my scholarly
project to improve
diabetes self-care
management

Level 4:
CrossSectional
Design

Small sample
size using
only one
homogeneous
group in South
Korea,
inability to
generalize
findings

Yes, this study could
be useful as it
provided a positive
correlation between
self-care management
and self-efficacy of a
patient with T2DM
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Cheng, L., Sit, J. W.
H., Leung, D. Y. P.,
& Li, X. (2016). The
association between
self-management
barriers and selfefficacy in Chinese
patients with type 2
diabetes: The
mediating role of
appraisal.
Worldviews on
Evidence-Based
Nursing, 13(5), 356–
362.
doi:10.1111/wvn.121
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Fioravanti, A., Fico,
G., Salvi, D., GarcíaBetances, R. I., &
Arredondo, M. T.
(2015). Automatic
messaging for
improving patients
engagement in
diabetes
management: An
exploratory study.
Medical & Biological

management
in T2DM
Korean
patients
requiring
insulin
therapy
To examine
the potential
role of
diabetes
appraisal on
the
association of
self-efficacy
and selfmanagement
barriers in
patients with
type two
diabetes

To identify if
a text
message with
the proper
context, sent
at the proper
time, has an
impact on a
patient’s
adherence to
therapy

diabetes selfefficacy when
educating and
counseling
patients
346 Adults
with type
two diabetes
mellitus from
4 hospitals in
China

A crosssection study

Significant
associations
were detected
between
diabetes
appraisal and
diet
knowledge, p
value of 0.047

Level 4:
CrossSectional
Study

Inability to
generalize
findings,
sample size
was obtained
from only four
teaching
hospitals in
China; Data
were selfreported

Yes, this research
study provides
evidence in the
relationship between
self-efficacy and diet
knowledge; utilizing
this information will
be of great use for
future research

51/54
patients
completed
(T1DM 1
and T2DM)
-26
Intervention
-25 Control

An
exploratory
randomized
control trial

The mobile
health system
(METABO)
was well
accepted and
utilized among
the patients;
prescription
adherence
increased
during the short
time frame

Level 2:
Welldesigned
RCT

Small sample
size, shorttime frame (4
weeks);
therefore,
inability to
generalize
findings

Yes, this article
provides evidence to
support the use of
automated text
messages for the
improvement in
patient adherence,
self-management, and
self-efficacy; however,
additional studies are
needed due to the
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Kocoglu, D. (2018).
Self-efficacy level
among patients with
type 2 diabetes living
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18(1), 4262.
doi:10.22605/RRH42
62
Huygens, M. W. J.,
Swinkels, I. C. S., de
Jong, J. D.,
Heijmans, M. J. W.
M., Friele, R. D., van
Schayck, O. C. P., &
de Witte, L. P.
(2017). Selfmonitoring of health
data by patients with
a chronic disease:
Does disease
controllability
matter? BMC Family
Practice, 18, 1–10.
doi:10.1186/s12875017-0615-3

short time frame of
this particular study

To determine
the disease
management
self-efficacy
level of
patients living
in a rural area
of Turkey
with T2DM
To investigate
the
relationship
between
patients’
willingness to
self-monitor
and control
chronic
diseases

216 Adult
patients with
T2DM; data
collections
from April to
June 2015
using the
Self-Efficacy
Scale for
Type 2
Diabetes
627
participants
from a Dutch
Panel
-17 Chronic
diseases
(diabetes,
heart failure,
asthma,
COPD,
hypertension,
migraines,
etc.)

A nonexperimental
, descriptive
survey

T2DM patients
living in rural
areas of Turkey
had moderate
self-efficacy
levels and poor
disease
management
levels

Level 6:
descriptive
design

Inability to
generalize
findings, due
to the
collection of
patients from
one hospital in
one area

Yes, this study does
provide helpful
information that could
assist in future
research; this study
identifies the need to
improve self-efficacy
through diabetes
education programs in
rural areas

CrossSectional
Study

Patients
willingness to
self-monitor
their disease
depends highly
among their
type of disease;
patients with
diabetes,
asthma, and
hypertension
are more likely
to self-monitor
their disease
when provided
appropriate
self-monitoring
parameters and
applications; an
association

Level 4:
Crosssectional
Study

Broad sample
size with
multiple
chronic
disease
processes’;
different
sample sizes
per each
chronic
disease

Yes, this article
provides evidence that
DM patients are
willing to self-monitor
their chronic disease
when provided
appropriate parameters
and tools; this study
can be used to support
diabetes education,
self-management, and
self-efficacy in future
research
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Koonce, T. Y.,
Giuse, N. B.,
Kusnoor, S. V.,
Hurley, S., & Ye, F.
(2015). A
personalized
approach to deliver
health care
information to
diabetic patients in
community care
clinics. Journal of the
Medical Library
Association, 103(3),
123–130.
doi:10.3163/15365050.103.3.004

To investigate
if educational
materials
targeted to
health literacy
levels and
learning styles
in a
community
clinic could
improve
diabetes
knowledge

160
Participants
(English or
Spanish
speaking,
18yrs or
older, with
type 2
diabetes)
-81
Intervention
-79 Control

Randomized
control trial

between
disease
controllability
and selfmonitoring
revealed an
association that
should be
further
investigated
After 2 weeks
(p = 0.0000 and
after 6 weeks
(p = 0.00) the
mean number
of diabetes
knowledge
questions were
increased
significantly in
the intervention
group; this
study identified
that diabetes
knowledge
significantly
increases after
exposure to
educational
materials
targeted to their
learning style
preference and
health literacy
levels

Level 2:
Welldesigned
RCT

The average
patient in this
study was
tested to have
“adequate”
health literacy;
short-term
study (6
weeks)

Yes, this study
provides evidence that
targeting health
literacy, learning
styles can improve
disease management
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(2018). Impact of
short message service
(SMS) education
based on a health
promotion model on
the physical activity
of patients with type
II diabetes.
Malaysian Journal of
Medical Sciences,
25(3), 67–77.
Retrieved from
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To evaluate
the impact of
a short
message
service (SMS)
based on a
health
promotion
model on the
physical
activity of
diabetes
patients

74 T2DM;
37 in SMS
group, 36 in
a control
group

QuasiExperimental
Study

Linnemayr, S.,
Huang, H., Luoto, J.,
Kambugu, A.,
Thirumurthy, H.,
Haberer, J. E., . . .
Mukasa, B. (2017).
Text messaging for
improving
antiretroviral therapy
adherence: No effects
after 1 year in a
randomized
controlled trial
among adolescents
and young adults.
American Journal of

To assess the
effectiveness
of short
message
service (SMS)
reminder
messages on
antiretroviral
and
cotrimoxazole
prophylaxis
adherence
among HIVpositive
youths

332
Participants
from 2 HIV
clinics in
Kampala

Year-long,
parallel,
individualrandomized
control trial

When
compared to
the control
group, the
SMS/training
group had
changes in
mean scores of
family support
(p = 0.001) and
self-efficacy (p
= 0.001) of
physical
activity and
perceived
barriers were
significantly
reduced over
time (p <
0.001)
Previous
evidence
reported SMS
reminder
interventions
were helpful in
the promotion
of antiretroviral
adherence;
however, this
study revealed
that SMS is not
always
effective in
behavioral
change

Level 3:
QuasiExperiment
al Design

Small sample
size, inability
to generalize
findings

Yes, this study
demonstrates that
SMS can change
beliefs and physical
activity behaviors in
DM patients

Level 2:
Welldesigned
RCT

No limitations
identified; per
study the
African setting
could be
generalizable
to other
settings in
Africa

This study was useful
in the evaluation of
SMS reminder
messages; this study
did not provide
sufficient evidence for
future use
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G. (2017). Text
messaging (SMS) as
a tool to facilitate
weight loss and
prevent metabolic
deterioration in
clinically healthy
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To assess the
efficacy of a
short message
service (SMS)
text message
and
interactive
voice
response
(IVR)
intervention
to promote
adherence in
T2DM
patients

80 Adults
classified
with low
socioeconom
ic status
(SES) and
type two
diabetes

QuasiExperimental
Design

To examine
whether a
short message
service (SMS)
text
messaging
facilitates a
reduction in
waist
circumference
(WC), weight,
insulin levels,

123
overweight
and obese
men and
women, with
no diabetes
or
cardiovascul
ar disease

A
randomized
controlled
trial

Compared to
baseline
measures,
adherence
measures
improved at
one and two
months; the
Messaging for
Diabetes
(MED) SMS
intervention
had a positive,
short-term
impact on
adherence but
did not
improve
glycemic
control
SMS
messaging in a
clinically
health
overweight and
obsess subject
does facilitate a
slight decrease
in WC, weight,
and BMI.

Level 3:
QuasiExperiment
al Design

Participants
received
monetary
compensation;
small sample
size, inability
to generalize
findings

This study provides
sufficient evidence to
use in future studies

Level 2:
Welldesigned
RCT

Small sample
size, subjects
with comorbid
conditions
were
excluded,
inability to
generalize
findings

This study provides
sufficient evidence to
support the use of
SMS in selfmanagement
promotion behaviors;
this would be a good
source to support
future evidence

66

COMBINATION THERAPY FOR TYPE TWO DIABETES MELLITUS
randomized
controlled trial.
Scandinavian
Journal of Primary
Health Care, 35(3),
262–270.
doi:10.1080/0281343
2.2017.1358435
Tharek, Z., Ramli, A.
S., Whitford, D. L.,
Ismail, Z., Zulkifli,
M. M., Ahmad
Sharoni, S. K., . . .
Jayaraman, T.
(2018). Relationship
between selfefficacy, self-care
behaviour and
glycaemic control
among patients with
type 2 diabetes
mellitus in the
Malaysian primary
care setting. BMC
Family Practice, 19,
39.
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van Velthoven, M.
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Q., Li, Y.,
Scherpbier, R. W.,
Du, X., . . . Rudan, I.
(2018). Comparison
of text messaging
data collection vs

and lipid
profiles in
clinical
healthy
overweight
and obese
subjects
To determine 340 Patients
the
with type
relationship
two diabetes
between selfefficacy, selfcare behavior,
and glycemia
control among
patients with
type two
diabetes in a
Malaysian
primary care
clinic

CrossSectional
Study

Higher selfefficacy was
correlated with
improved
glycemic
control and
better self-care
behaviors

Level 4:
CrossSectional
Study

Nonprobability
sampling
method, selfreported
methods

This study does
provide a good source
of evidence in the
correlation of selfefficacy and glycemic
control

To compare
text
messaging
and face-toface
interviews for
a public
health survey

Cluster,
RandomizedCrossover
Study

This study
revealed that
text messaging
data produces
similar data
when compared
to face-to-face
interviews in a

Level 2:
Welldesigned
RCT

Poor
communicatio
n, challenging
situations;
inability to
generalize
findings due
to the

This study would not
be useful for future
research support for
this student

1014
participants:
only 662
responded,
651 agreed to
participate;
Only 356
completed
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on childhood
pneumonia
and diarrhea

the text
message
survey

middle-income
setting

collection area
being from
one rural area
of China, this
study could
not be
generalized to
other rural
areas in China
with similar
socioeconomic
characteristics
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Appendix G
Advertisement

Participants Needed!

TYPE 2 DIABETIC?
Sponsored & Conducted By: Crystal Masling, Family Nurse Practitioner Student,
Liberty University

Eligibility Requirements:

Clinical Study Requirements:

o Patients diagnosed with
type 2 diabetes for at
least one year
o At least 18 years old
o Access to a cell phone
o Ability to read, write,
and speak English
o Associate’s degree or
less

o Two meetings with study
leader over 3 month time to
include 2 questionnaires,
collection of vital signs
(weight, blood pressure,
pulse), A1c checks, and
education.
o Daily blood sugar checks
o Daily/Weekly text
messages

All participants will be compensated with a $5
Walmart gift card
Three grand prize winners
Grand prizes to include: 40” Smart TV, Amazon
Fire 7 Tablet & Wireless Bluetooth Headphones
Please see the receptionist for further questions and sign-up instructions J!
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Appendix H
Physician Recruitment Letter
[Insert Date]
Trinity Medical Care, P.C.
1509 E. Innes Street
Salisbury, N.C. 28146
Met with Mr. L. Jeffery Taylor P.A.-C
Explained my role and topic: As a graduate student in the School of Nursing at Liberty
University, I am conducting research as part of the requirements for a Doctor of Nursing Practice
– Family Nurse Practitioner degree. The purpose of my research is to identify if a health literate
specific diabetic education program when combined with a daily short message service (SMS)
intervention can improve glycemic control and self-efficacy in the type two diabetic patient over
a 3-month time frame.
Explained my project inclusion and exclusion criteria: participants must be 18 years of age or
older, have a diagnosis of type two diabetes, have had diabetes for at least one year or longer,
have access to a mobile device, English-speaking, have the ability to read and write in English
and have an associate’s degree or less.
Explained project guidelines: participants will be asked to complete the following: (1) attend
two meetings with the project leader (2) perform daily blood sugar checks; and (3) interact
through text messages with the project leader.
Mr. Taylor expressed great interest in project topic and gave verbal consent to use medical
practice. Together collaborated to identify appropriate times for participant meetings, time
length, and advertisement options. Mr. Taylor agreed to send official letter of support and
offered assistance for scholarly project.
Physician Script for Recruitment:
• Mr. Taylor will inform patients that the study is being conducted by Crystal Masling, a
Family Nurse Practitioner Student at Liberty University. He will inform the potential
participant that the study has no association with Trinity Medical Care. He will then
inform the individual of eligibility requirements: patients diagnosed with type two
diabetes mellitus for at least one year, at least 18 years old, access to a cell phone, ability
to read, write, and speak English, and have an associate’s degree or less.
• Mr. Taylor will tell the individual that the clinical study will require two meetings with
the nurse practitioner student over a 3-month period; one in the beginning and one at the
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•

•
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end. He will inform them that they will have their HbA1c value collected (1cc of blood
via finger stick), their vital signs, and weight documented at no charge. During the
scheduled meeting, the nurse practitioner student will go over an education document and
provide a 3-month clinical study overview; which will include daily blood sugar checks,
weekly and daily text messages.
Mr. Taylor will inform the potential participant of the monetary and grand prize
compensation. If he/she expresses interest, Mr. Taylor will provide him/her with the prestamped recruitment and enrollment eligibility survey that will need to be completed and
mailed back to the medical office.
Mr. Taylor will be prepared to answer all questions regarding the clinical study.
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Appendix I
Patient Recruitment Form
[Insert Date]
[Recipient]
[Address 1]
[Address 2]
[Address 3]
Dear [Recipient]:
As a graduate student in the School of Nursing at Liberty University, I am conducting research
as part of the requirements for a Doctor of Nursing Practice – Family Nurse Practitioner degree.
The purpose of my research is to identify if a health literate specific diabetic education program
when combined with a daily short message service (SMS) intervention can improve glycemic
control and self-efficacy in the type two diabetic patient over a 3-month time frame, and I am
writing to invite you to participate in my study.
If you are 18 years of age or older, have a diagnosis of type two diabetes, have had diabetes for
at least one year or longer, have access to a mobile device, English-speaking, have the ability to
read and write in English, have an associate’s degree or less, and are willing to participate, you
will be asked to: (1) attend two meetings with the project leader (2) perform daily blood sugar
checks; and (3) interact through text messages with the project leader. During the two schedule
meetings your vital signs will be taken including weight, blood pressure, and pulse. You will be
asked to complete two questionnaires and have your A1c value drawn; all free of charge (no
insurance charges). The meetings will take place at the beginning of the study and at the end;
approximately 90 days (3 months) apart. The first meeting will also include the receipt of an
educational packet and will take approximately 45 minutes to complete the procedures listed.
The second meeting will take approximately 20-30 minutes to complete. During the 90 days, you
will be asked two SMS (text message) questions each day and one SMS (text message) question
each week. The daily text messages should take no longer than 4 minutes to complete, the
weekly text message should take no longer than 5 minutes to complete. Your name and other
identifying information will be requested as part of this study, but the information will remain
confidential.
To participate, please complete the attached enrollment eligibility document and return it to
Trinity Medical Care in the pre-stamped envelope by the indicated date. You will be contacted
by phone to schedule the first meeting with the researcher once eligibility requirements have
been reviewed.
A consent document will be given to you at the time of the first meeting. The consent document
contains additional information about my research. You will be asked to sign the consent
document and return it to me at the time of the meeting.
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If you choose to participate, you will be entered to win one of three grand prizes. The overall
grand prize winners will be chosen based upon (1) self-efficacy & health literacy score
improvements; (2) A1c reduction values; and (3) involvement in text messages over the 90-day
time frame. The grand prize winner will receive a 40-inch smart television ($100.00 value). The
second grand prize winner will receive a Fire 7 HD Tablet ($29.99 value), and the third grand
prize winner will receive a pair of wireless Bluetooth Skull headphones ($19.99 value). All
participants who complete the study entirely will receive a $5.00 Walmart gift card.
Sincerely,
Crystal Manus Masling
RN, BSN, CCRN
Liberty University, DNP-FNP Student
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Appendix J
Enrollment Eligibility Questionnaire
Name: ______________________________________________________________
Address: _____________________________________________________________
Date of Birth: _________________________________________________________
Home Phone: _________________________________________________________
Cell Phone: ___________________________________________________________
Highest Level of Completed Education:
Less than high
High school or
Some college,
school
GED
no degree

Associate degree

Please circle yes or no for the following questions:
1. Have you been diagnosed with type 2 diabetes for one year or longer?
Yes
No
2. Do you have a cell phone?
Yes

No

3. Can you receive text messages?
Yes

No

4. Are you comfortable with receiving text messages?
Yes
No
5. Can you send text messages?
Yes

No

6. Are you comfortable with sending text messages?
Yes
No
7. Can you speak English language?
Yes

No

Bachelor’s
degree or higher
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8. Can you read English language?
Yes

No

9. Can you write English language?
Yes

No
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Appendix K
Patient Demographic Questionnaire
Name: _______________________________________________________________
Address: _____________________________________________________________
Date of Birth: _________________________________________________________
Home Phone: _________________________________________________________
Cell Phone: ___________________________________________________________
Gender: _____________________________________________________________
Race/Ethnicity:
White

Black

Hispanic

Other
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Appendix L
Short Message Service (SMS) Document
SMS Part One: Daily Text Message
When

Question

Response

Daily

1. Did you take your blood sugar medicine?

(1) Yes
(2) No

Daily

2. Did you check your blood sugar today?

(1) Yes
(2) No

SMS Part Two: Weekly “Pop-Quiz”
Week Question
1
If your blood sugar is low (less than 70mg/dL) what
can you eat for a “quick-fix”?

Response
(1) Hard Candy
(2) 4oz. of Juice
(3) 2 tbsp. of raisins
(4) All of the above

2

How should your meal plate be proportioned to
follow the Diabetes Plate method?

(1) ½ Vegetables, ½
Carbohydrates
(2) ½ Vegetables, ½ Protein
(3) ½ Vegetables, ¼
Carbohydrates, ¼ Protein
(4)1/2 Protein, ½
Carbohydrates

3

A 4oz serving size of meat can be compared to what?

4

Half of your plate should be filled with what type of
foods?

(1) A deck of cards
(2) A tennis ball
(3) The palm of your hand
(4) A softball
(1) Carbohydrates
(2) Non-Starchy Vegetables
(3) Protein
(4) Fats

5

What is the normal blood sugar range before a meal?

(1) 80-100 mg/dL
(2) 80-130 mg/dL
(3) 70-120 mg/dL
(4) 80-140 mg/dL
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6

Type two diabetes is caused by?

7

Type two diabetes can be prevented through?

8

An A1c value shows an average blood sugar over
how many months?

(1) Two to three months
(2) One to three months
(3) One month
(4) Six months

9

How many minutes a week should you exercise?

(1) 200
(2) 100
(3) 150
(4) 30

10

What type of exercise is best for a diabetic patient?

(1) Low intensity
(2) Moderate intensity
(3) High intensity
(4) Non-Strenuous

11

All of the following are considered moderate intensity (1) Yard work
exercises except which one?
(2) Cleaning house
(3) Walking
(4) High Intensity Interval
Training

12

Physical activity improves

84

(1) Insulin resistance
(2) Weight loss
(3) Genetics
(4) Hereditary
(1) Proper Diet
(2) Exercise
(3) Blood Pressure below
140/90mmHg
(4) All of the above

(1) Heart Health
(2) Insulin Sensitivity
(3) Weight Loss
(4) All of the above

Notes:
o All answers are highlighted in yellow except for the daily questions.
o There are 12 total questions equally divided; 4 for nutrition, 4 for exercise, and 4 for type
two diabetes.
o All participants will be asked to answer the questions to the best of their abilities. All
questions have been derived from the health literacy document. If the participant selects
the wrong answer, then they will be provided an automated response with the correct
answer.
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Appendix M
Instructions for Short Message Service (SMS)
Question One:
Did you take your blood sugar medicine?
Reply on your cellphone
Number/Key One for Yes if you took for your medicine
Number/Key Two for No if you did not take your medicine
Question Two:
Did you check your blood sugar?
Reply on your cellphone
Number/Key One for Yes if you checked your blood sugar today
Number/Key Two for No if you did not your blood sugar today

Weekly Friday Pop-Quiz Question:
Each week the question will change, you will receive an image with a question such as:
Example:

Reply on your cellphone with the number/key of the answer you think is the correct answer
*For this example: You would reply 2 and hit send.
The normal blood sugar range before a meal is 80 – 130 mg/dL
*Note: if the answer you choose is incorrect, the correct answer will be sent back in a text
message
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Appendix N
Completion
Planning
Date
7/11/2019
Meet with scholarly project chair
to present project idea and
development
8/07/2019

Receive project chair approval,
then identify key stakeholders to
individually obtain their support

8/16/2019

Liberty University School of
Nursing affiliation agreement with
Private Family Practice and
primary care provider, PA-C
received
Meet with primary care provider,
PA-C to present project topic,
receive verbal endorsement letter
of support from Private Family
Practice
Meet with scholarly project chair
to discuss proposal, project
outcomes, and measurement tools

8/19/2019

8/21/2019

10/2019
10/26/2019

Scholarly Project Timeline
Pre-Implementation

Begin and draft pre-proposal for
IRB submission
Submit pre-proposal to
scholarly project chair

Implementation

Evaluation
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11/2019
12/2019

Perform mini-project
presentation to scholarly
project chair
Submit IRB application

01/2020

Receive IRB application
Meet with primary care
provider, PA-C and office
staff, provide project overview,
post advertisement flyers
Print hardcopies of diabetes
education

03/16/2020
03/16/2020

03/16/2020
–
06/18/2020

Implement diabetes HL
project for three months
Obtain consent from all
participants and complete
all pre-study
questionnaires; complete
trial text message while in
office “Did you take your
blood sugar medicine
today?”
Send daily and weekly
SMS engagement text
messages to enrolled
participants during threemonth period; input
response data into
Microsoft Excel
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06/18/2020

Conclude three-month
diabetes HL scholarly
project; Meet with project
participants, collect poststudy data

06/18/2020

06/26/2020

07/2020

Analyze SMS
data in Microsoft
Excel
Utilize SPSS
software to
analyze data;
prepare
presentation

Notify winners,
compensate accordingly,
mail “thank you” letters to
all participants
Present data

